Syndax Pharmaceuticals (SNDX) PT Raised to $34 at Barclays
Tweet
Share
E-mailGet Alerts SNDX Hot Sheet
Price: $19.08 -3.64%
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Barclays analyst Peter Lawson raised the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $34.00 (from $31.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
- Lotes Co Ltd (3533:TT) PT Lowered to NT$2,720 at Nomura/Instinet
- JPMorgan Downgrades HomeCo Daily Needs REIT (HDN:AU) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
